Koers Radiko Holdings Corp. Canadian Securities Exchange
Aandelen
JUJU
CA75034R1029
Farmaceutische producten
Omzet 2018 | 107K 145K 98,28K | Omzet 2019 | 5,18 mln. 7,06 mln. 4,78 mln. | Marktkapitalisatie | 6,17 mln. 8,4 mln. 5,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -5,45 mln. -3,69 mln. | Nettowinst (verlies) 2019 | -10 mln. -13,62 mln. -9,22 mln. | EV/omzet 2018 | 101 x |
Nettoschuld 2018 | 259K 352K 239K | Nettoschuld 2019 | 1,98 mln. 2,7 mln. 1,83 mln. | EV/omzet 2019 | 1,57 x |
K/w-verhouding 2018 |
-1,5
x | K/w-verhouding 2019 |
-0,53
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 96,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 734 mld. | |
+32,83% | 591 mld. | |
-6,30% | 350 mld. | |
+15,15% | 315 mld. | |
+4,05% | 276 mld. | |
+15,00% | 238 mld. | |
+9,78% | 206 mld. | |
-5,52% | 204 mld. | |
+6,17% | 161 mld. |